Pregnyl (Chorionic Gonadotropin) Information & Coordination for Licensed U.S. Clinics
Pregnyl (chorionic gonadotropin) is an FDA-licensed prescription biological product. Current U.S. labeling identifies Pregnyl as a sterile, dried preparation for intramuscular administration after reconstitution, supplied as a multiple-dose vial containing 10,000 USP units of chorionic gonadotropin for use in one patient.
Pregnyl has specific labeled uses in reproductive and endocrine care. Those uses should be distinguished from broader wellness, weight-management, hormone-optimization, or other applications that are not part of the product’s labeled indications.
Phoenix Meds Inc. supports licensed healthcare organizations with credential review, documentation, publicly available product and regulatory information, and administrative coordination.
We are not a pharmacy, medical practice, manufacturer, prescriber, wholesaler, distributor, or dispensing entity.
What Clinics Should Know About Pregnyl
Pregnyl contains chorionic gonadotropin, a gonadotropin hormone.
Its current U.S. labeling includes three principal uses:
- certain cases of prepubertal cryptorchidism not caused by an anatomical obstruction;
- selected cases of hypogonadotropic hypogonadism in males; and
- induction of ovulation and pregnancy in certain anovulatory infertile women whose condition is secondary rather than due to primary ovarian failure and who have received appropriate gonadotropin treatment.
Current Pregnyl labeling also specifically states that hCG has not been demonstrated to be effective as adjunctive therapy for obesity and that there is no substantial evidence that it increases weight loss beyond caloric restriction.
These indications and the associated patient-selection requirements come from the product labeling. Clinical decisions remain with the treating licensed healthcare professional.
Phoenix does not provide diagnosis, dosing, administration schedules, patient-selection advice, or treatment protocols.
Product-Specific Labeling Matters
Pregnyl should not be treated as interchangeable with every product described as “hCG.”
The current Pregnyl label identifies a 10,000 USP-unit multiple-dose vial, supplied with diluent, for intramuscular administration after reconstitution. Exact labeling, packaging, NDC information, manufacturer information, and handling instructions should be checked against the specific product being supplied.
That distinction also matters when discussing commercially manufactured Pregnyl versus compounded chorionic gonadotropin preparations. A page specifically about Pregnyl should not mix the branded product’s regulatory status with statements about compounded hCG.
Sterile Compounding and Ingredient Quality
The current Pregnyl labeling states that the unopened product should be stored at controlled room temperature, 15°C to 25°C (59°F to 77°F).
After reconstitution, if the solution is not used immediately, the label directs refrigerated storage at 2°C to 8°C (36°F to 46°F) and disposal after 60 days. The label also instructs not to freeze the reconstituted product.
This is important because the old page’s statement that Pregnyl must always be shipped and received under a refrigerated “cold chain” is too broad. Storage and shipping requirements should follow the actual product labeling and the responsible pharmaceutical entity’s procedures.
How Phoenix Meds Supports Licensed Clinics
Phoenix’s role is administrative.
We may assist licensed healthcare organizations with matters such as professional credential review, organization of available documentation, review of publicly available product labeling and regulatory information, and administrative communication relating to documentation.
Where a clinic already has an appropriate licensed pharmaceutical relationship, Phoenix may also help organize supplier-provided administrative documents and identify missing or inconsistent information for follow-up by the responsible parties.
Phoenix does not determine whether Pregnyl is clinically appropriate for a patient and does not certify a product’s authenticity, quality, regulatory status, storage history, or suitability.
Documentation Review
For a branded prescription product such as Pregnyl, documentation should match the actual product involved.
Relevant information may include product identity, labeled strength, manufacturer or labeler information, NDC information, expiration information, storage requirements, and other documentation supplied by the responsible pharmaceutical party.
Phoenix may help organize this material for clinic review but does not independently authenticate or certify pharmaceutical products.
Pregnyl Administrative Coordination for Licensed Clinics
Licensed healthcare organizations may contact Phoenix Meds Inc. for administrative support relating to clinic credentials, documentation, product information, and publicly available regulatory materials concerning Pregnyl. An administrative inquiry is not a medication order and does not establish product availability, pricing, clinical appropriateness, or eligibility for a particular distribution pathway.
Clinic Verification
Documentation Review
Phoenix may help organize available product and administrative documentation for review by the clinic and other responsible licensed parties.
Licensed Parties
Prescribing, dispensing, distribution, storage, shipping, patient counseling, and other regulated pharmaceutical and clinical activities remain with the parties legally authorized and responsible for performing them.
Frequently Asked Questions
What is Pregnyl?
Pregnyl is a prescription chorionic gonadotropin product. Current labeling describes it as a sterile dried preparation containing 10,000 USP units per vial for intramuscular administration after reconstitution.
What are Pregnyl’s labeled uses?
Its labeling covers certain cases of prepubertal cryptorchidism, selected cases of hypogonadotropic hypogonadism in males, and induction of ovulation and pregnancy in certain anovulatory infertile women meeting the labeled criteria.
Is Pregnyl the same as compounded hCG?
No. Pregnyl is an FDA-licensed biological product marketed under BLA 017692. A compounded preparation containing chorionic gonadotropin is a separate product and should not be represented as Pregnyl simply because it contains hCG.
Is Pregnyl a federally DEA-scheduled controlled substance?
Current DailyMed product information lists Pregnyl as DEA Schedule: None. Credentialing requirements may still vary according to the organization, transaction, and applicable state or institutional requirements.
Does Pregnyl have to remain refrigerated before use?
The current labeling states that the unopened product is stored at controlled room temperature. Refrigerated storage applies after reconstitution if the solution is not used immediately.
Does Phoenix meds provide dosing or fertility-treatment protocols?
No. Phoenix does not provide diagnosis, dosing, administration instructions, treatment protocols, or patient-specific medical advice.
Does Phoenix Meds guarantee product authenticity or traceability?
No. Phoenix may help organize documentation provided by responsible third parties, but it does not independently certify authenticity, chain of custody, product quality, or regulatory compliance.
Important Notice
Phoenix Meds Inc. provides administrative coordination, documentation, and compliance-focused support for licensed healthcare organizations.
We are not a pharmacy, medical practice, manufacturer, prescriber, wholesaler, distributor, or dispensing entity.
Clinical decisions concerning Pregnyl—including diagnosis, patient selection, prescribing, dosing, administration, monitoring, and treatment—remain with appropriately licensed healthcare professionals. Product handling and pharmaceutical distribution remain with the responsible licensed parties.